2017
DOI: 10.1007/s12410-017-9428-y
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac CT for Guiding Mitral Valve Interventions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 79 publications
0
5
0
Order By: Relevance
“…As its name suggests, it consists of a clip that allows capturing both the anterior and posterior mitral leaflets with its two arms, resulting in shrinking of the regurgitant mitral valve orifice. TMVRep with Mitraclip ® is performed using a trans-septal approach with 3D-transesophageal echocardiography as the gold standard for preprocedural planning and intraoperative guidance, although MDCT can provide incremental anatomical data such as for the severity assessment of mitral valve calcifications (which may interfere with or contraindicate device implantation) [ 6 , 11 , 12 ]. Among current percutaneous treatment options, Mitraclip ® -based edge-to-edge TMVRep is the most commonly performed transcatheter mitral valve procedure, has gained both CE and FDA approval, and although the rate of residual MR up to 5 years is higher than with surgical repair, it is generally safe and can improve symptoms while inducing reverse left ventricular remodelling [ 13 ].…”
Section: Transcatheter Mitral Valve Procedures: When and How?mentioning
confidence: 99%
See 4 more Smart Citations
“…As its name suggests, it consists of a clip that allows capturing both the anterior and posterior mitral leaflets with its two arms, resulting in shrinking of the regurgitant mitral valve orifice. TMVRep with Mitraclip ® is performed using a trans-septal approach with 3D-transesophageal echocardiography as the gold standard for preprocedural planning and intraoperative guidance, although MDCT can provide incremental anatomical data such as for the severity assessment of mitral valve calcifications (which may interfere with or contraindicate device implantation) [ 6 , 11 , 12 ]. Among current percutaneous treatment options, Mitraclip ® -based edge-to-edge TMVRep is the most commonly performed transcatheter mitral valve procedure, has gained both CE and FDA approval, and although the rate of residual MR up to 5 years is higher than with surgical repair, it is generally safe and can improve symptoms while inducing reverse left ventricular remodelling [ 13 ].…”
Section: Transcatheter Mitral Valve Procedures: When and How?mentioning
confidence: 99%
“…In fact, the majority of percutaneous mitral valve prostheses are positioned via a transapical approach (i.e. through puncture of the left ventricular apex), whereas others are deployed through a trans-septal (venous) approach, which would be ideal in highest risk patients [ 11 , 12 , 14 , 15 ]. Encouraging data have recently been provided by a feasibility study ( NCT02321514 ) about the effectiveness and safety of transapical TMVR using a self-expanding device in patients with native MR at high risk for cardiac surgery, resulting in NYHA functional class improvement with mild or no symptoms in 75% of patients and successful device implantation without cardiovascular mortality, stroke, and device malfunction in 86.6% of patients at 30-day follow-up [ 16 ].…”
Section: Transcatheter Mitral Valve Procedures: When and How?mentioning
confidence: 99%
See 3 more Smart Citations